Old Web
English
Sign In
Acemap
>
authorDetail
>
D. Torti
D. Torti
Medicine
non-small cell lung cancer (NSCLC)
Erlotinib
Cancer research
Oncology
3
Papers
0
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
P35.03 Methylation Signatures Associated with T790M Status in Progressive NSCLC
2021
Journal of Thoracic Oncology
Grainne M. OKane
A. León
M Shabir
J Law
P.A. Bradbury
G. Liu
Adrian G. Sacher
F. Shepherd
D. Torti
T. Stockley
Ming Tsao
Trevor J. Pugh
Natasha B. Leighl
Show All
Source
Cite
Save
Citations (0)
Erlotinib (E) treatment after failure of gefitinib (G) in advanced non-small-cell lung cancer (NSCLC) patients previously responding to EGFR tyrosine Kinase inhibitors (TKI)
2008
Enrico Vasile
C. Tibaldi
Antonio Chella
M. Lo Dico
E. Mazzoni
Armida D’Incecco
D. Torti
A Di Giulio
F. Borghi
M. Andreuccetti
Nicolino Ambrosino
Alfredo Falcone
Show All
Source
Cite
Save
Citations (0)
EGFR/KRAS-Germline mutation analyses in advanced non-small cell lung cancer (NSCLC) patients treated with Gefitinib/Erlotinib
2008
C. Tibaldi
E. Giovannetti
Enrico Vasile
D. Torti
Marielle I Gallegos-Ruiz
Sara Nannizzi
M. Del Tacca
Godefridus J. Peters
Alfredo Falcone
R. Danesi
Show All
Source
Cite
Save
Citations (0)
1